A randomized, controlled trial of amitriptyline in the acute treatment of adolescent major depression

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 35, Issue 9, 1996, Pages 1139-1144

  Kye, Christopher H ^a   Waterman, G Scott ^b   Ryan, Neal D ^a   Birmaher, Boris ^a   Williamson, Douglas E ^a   Iyengar, Satish ^a   Dachille, Susan ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

adolescent; major depression; treatment; tricyclic antidepressant

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; FLUOXETINE; PLACEBO; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; ANOREXIA; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HAMILTON SCALE; HUMAN; MALE; MORBIDITY; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGIC ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VISUAL IMPAIRMENT;

EID: 0029788087     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004583-199609000-00011     Document Type: Article

References (32)

1. Ambrosini PJ, Bianch MD, Metz C, Rabinovich H (1994), Evaluating clinical response of open nortriptyline pharmacotherapy in adolescent major depression. J Child Adolesc Psychopharmacol 4:233-244
2. American Psychiatric Association Task Force on the Use of Laboratory Tests in Psychiatry (1985), Tricyclic antidepressants; blood level measurements and clinical outcome. An APA Task Force Report. Am J Psychiatry 142:155-162
3. Chambers W, Puig-Antich J, Hirsch M et al. (1985), The assessment of affective disorders in children and adolescents by semistructured interview: test-retest reliability of the Schedule for Affective Disorders and Schizophrenia for School-Age Children, Present Episode Version. Arch Gen Psychiatry 42:696-702
4. Depression Guideline Panel (1993), Clinical Practice Guideline. Depression in Primary Care, Vol 2: Treatment of Major Depression (AHCPR Publication 93-0551). Rockville, MD: US Department of Health and Human Services, Agency for Health Care Policy and Research
5. Frank E, Kupfer D, Perel J et al. (1990), Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry 47:1093-1099
6. Geller B, Cooper T, Graham D, Marsteller F, Bryant M (1990), Double-blind placebo-controlled study of nortriptyline in depressed adolescents using a "fixed plasma level" design. Psychopharmacol Bull 26:85-90
7. Geller B, Fox L, Fletcher M (1993), Effect of tricyclic antidepressants on switching to mania and on the onset of bipolarity in depressed 6- to 12-year-olds. J Am Acad Child Adolesc Psychiatry 32:43-50
8. Gibbons RD, Hedeker DR, Elkin I et al. (1993), Some conceptual and statistical issues in an analysis of longitudinal psychiatric data: application to the NIMH Treatment of Depression Collaborative Research Program dataset. Arch Gen Psychiatry 50:739-750
9. Goldman-Rakic P, Brown R (1982), Postnatal development of monamine content and synthesis in the cerebral cortex of rhesus monkeys. Dev Brain Res 4:339-349
10. Hamilton M (1981), A rating scale for depression. J Neurol Neurosurg Psychiatry 38:98-103
11. Harrington R, Fudge H, Rutter M, Pickles A, Hill J (1990), Adult outcomes of childhood and adolescent depression, I. Psychiatric status. Arch Gen Psychiatry 47:465-473
12. Heckman N (1985), A sequential probability ratio test using a biased coin design. Ann Stat 13:789-794
13. Hollingshead A (1976), Four Factor Index of Social Status: Working Paper. New Haven, CT: Yale University Press
14. Katchadourian H (1977), The Biology of Adolescence. San Francisco: WH Freeman
15. Kovacs M, Gastonis C (1989), Stability and change in childhood-onset depressive disorders: longitudinal course as a diagnostic validator. In: The Validity of Psychiatric Diagnosis, Robbins L, Barrett J, eds. New York: Raven Press, pp 57-76
16. Kramer A, Feiguine R (1981), Clinical effects of amitriptyline in adolescent depression. J Am Acad Child Psychiatry 20:636-644
17. Kutcher S, Boulos C, Ward B et al. (1994), Response to desipramine treatment in adolescent depression: a fixed-dose, placebo-controlled trial. J Am Acad Child Adolesc Psychiatry 33:686-694
18. Kye C, Ryan N (1995), Pharmacotherapy of child and adolescent depression. Child Adolesc Psychiatr Clin North Am 4:261-283
19. Morris J, Beck A (1974), The efficacy of antidepressant drugs. A review of research (1958-1972). Arch Gen Psychiatry 30:667-674
20. National Institute of Mental Health (1985), Special Feature: Rating Scales and Assessment Instruments for Use in Pediatric Psychopharmacology Research. Psychopharmacol Bull 21:839-844
21. Orvaschel H, Puig-Antich J (1987), Schedule for Affective Disorders and Schizophrenia for School-Age Children-Epidemiologic 4th Version. Ft Lauderdale, FL: Nova University, Center for Psychological Study
22. Puig-Antich J, Chambers W (1978), The Schedule for Affective Disorders and Schizophrenia for School-Age Children (Kiddie-SADS). New York: New York State Psychiatric Institute
23. Ryan N, Dahl R (1993), The biology of depression in children and adolescents. In: Biology of Depressive Disorders, Part B: Subtypes of Depression and Comorbid Disorders, Mann J, Kupfer D, eds. New York: Plenum, pp 37-58
24. Ryan N, Puig-Antich J, Ambrosini P et al. (1987), The clinical picture of major depression in children and adolescents. Arch Gen Psychiatry 44:854-861
25. Ryan N, Puig-Antich J, Cooper T et al. (1986), Imipramine in adolescent major depression: plasma level and clinical response. Acta Psychiatr Scand 73:275-288
26. Schluchter MD (1988), Unbalanced repeated measures models with structured covariance matrices. In: BMDP Statistical Software Manual, Vol 2, Dixon WJ, ed. Berkeley: University of California Press, pp 1081-1114
27. Simeon J, Dinicola V, Ferguson H, Copping W (1990), Adolescent depression: a placebo-controlled fluoxetine treatment study and follow-up. Prog Neuropsychopharmacol Biol Psychiatry 14:791-795
28. Spitzer R, Endicott J, Robins E (1977), Research Diagnostic Criteria (RDC) for a Selected Group of Functional Disorders, 3d ed. New York: Biometrics Research
29. Strober M, Freeman R, Rigali J (1990), The pharmacotherapy of depressive illness in adolescence: I. An open label trial of imipramine. Psychopharmacol Bull 26:80-84
30. Wei L (1977), A class of designs for sequential clinical trials. J Am Stat Assoc 72:382
31. Weissman M, Gammon G, John K et al. (1987), Children of depressed parents: increased psychopathology and early onset of major depression. Arch Gen Psychiatry 44:847-853
32. Williamson D, Ryan N, Dahl R, Jeannette L (1992), Hamilton depression scores can be extracted from the K-SADS-P in adolescents. J Child Adolesc Psychopharmacol 2:175-181